How many institutions held ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share in Q2 2022?

2 institutional investors reported ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO)

Q: What does CUSIP 98978N101 represent in this 13F holders report?

CUSIP 98978N101 is the security identifier for ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share used to aggregate holder disclosures.

CUSIP: 98978N101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $.001 per share
Shares outstanding: 3,908,612
Total 13F shares: 82,936
Share change: 0
Total reported value: $326,000
Price per share: $3.93
Number of holders: 2

Quarterly Holders Quick Answers

What is CUSIP 98978N101?
CUSIP 98978N101 identifies ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 98978N101:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Top shareholders of ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	322,017	$1,249,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	92,468	$359,000	—	31 Mar 2022	13F
Schechter Investment Advisors, LLC	13F	Company	1.5%	56,770	$220,000	—	31 Mar 2022	13F
CoreCap Advisors, LLC	13F	Company	0.67%	26,166	$102,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	13,313	$51,000	—	31 Mar 2022	13F
Verdence Capital Advisors LLC	13F	Company	— mixed-class rows	20,000 mixed-class rows	$45,000	—	31 Mar 2022	13F
Ayrton Capital LLC	13F	Company	— class O/S missing	48,850	$31,000	—	31 Mar 2022	13F
Warberg Asset Management LLC	13F	Company	— class O/S missing	26,180	$17,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	— mixed-class rows	6,436 mixed-class rows	$14,000	—	31 Mar 2022	13F
CVI Holdings, LLC	13F	Company	— class O/S missing	16,108	$10,000	—	31 Mar 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	1,010	$4,000	—	31 Mar 2022	13F
Bartlett & Co. LLC	13F	Company	— class O/S missing	1,000	$4,000	—	31 Mar 2022	13F
BARTLETT & CO. WEALTH MANAGEMENT LLC	13F	Company	— class O/S missing	1,000	$3,880	—	31 Mar 2022	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	— class O/S missing	626	$2,000	—	31 Mar 2022	13F
Andrew A. Dahl	3/4/5	President / CEO, Director	— class O/S missing	376,000	—	—	21 Oct 2021	3/4/5

Institutional Holders of Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) as of Q2 2022

As of 30 Jun 2022, Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,936 shares. The largest 2 holders included Schechter Investment Advisors, LLC and CoreCap Advisors, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.